A Study to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine

NCT03718468 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

842

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: GC FLU Quadrivalent
BIOLOGICAL: Fluarix Tetra

Sponsor

Medigen Vaccine Biologics Corp.